PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento. The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation’s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento’s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex’s transfer agent and requests that such firms contact Scilex’s transfer agent if they have not received such confirmation. The supplement also reiterates a question related to issues that may arise with respect to the dividend in connection with short positions in Sorrento common stock. The supplement to the FAQs and related annex are included in this press release and can also be found Scilex’s website https://www.scilexholding.com/investors/faqs/ SUPPLEMENT TO FREQUENTLY ASKED QUESTIONS REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY SORRENTO THERAPEUTICS, INC. This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (Sorrento) that was issued by Sorrento on January 29, 2023 (the FAQ), a copy of which can be found under the “Investors” section of its website at www.sorrentotherapeutics.com.
This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ. NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC Effective as of February 2, 2023, the Depository Trust and Clearing Corporation has removed the “contra-CUSIP” that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex’s CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock. NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex’s transfer agent immediately to obtain a copy of the Dividend Confirmation. Scilex’s transfer agent’s contact information is as follows: Continental Stock Transfer & Trust Company Telephone Number: 800-509-5586 Email Address: cstmail@continentalstock.com Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock SUPPLEMENTAL QUESTION AND ANSWER Q: If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date?
A: Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend Stock. Annex B Broker List Broker NameBroker Address Broker NameBroker AddressABN AMRO CLEARING CHICAGO LLC175 WEST JACKSON BLVD.CHICAGOIL ILLINOIS60604 US Albert Fried & Company LLC45 BROADWAY, 24TH FLOOR24TH FLOORNEW YORKNY NEW YORK10006 USAMALGAMATED BANK275 7TH AVENUENEW YORKNY NEW YORK10003 US AMERICAN ENTERPRISE INVESTMENT SERVICES INC.682 AMERIPRISE FINANCIAL CENTERMINNEAPOLISMN MINNESOTA55474 USAPEX CLEARING CORPORATION2 GATEWAY CENTER 283-299 MARKET ST16TH FLOORNEWARKNJ NEW JERSEY07102-5005 US BANK OF AMERICA, NA/GWIM TRUST OPERATIONS901 MAIN STREET12TH FLOORDALLASTX TEXAS23113 USBANK OF NEW YORK MELLON111 SANDERS CREEK PARKWAY 2ND FLOOR2ND FLOOREAST SYRACUSENY NEW YORK13057 US. BARCLAYS CAPITAL INC.DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZJERSEY CITYNJ NEW JERSEY07310 USBARCLAYS CAPITAL INC.DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZJERSEY CITYNJ NEW JERSEY07310 US BMO CAPITAL MARKETS CORP.3 2ND STREET12TH FLOORJERSEY CITYNJ NEW JERSEY07302 USBMO HARRIS BANK NA/TRUST11270 W PARK PLMILWAUKEEWI WISCONSIN53224 US BMO Nesbitt Burns Inc., Toronto250 YONGE STREET, 7TH FLOOR7TH FLOORTORONTOON ONTARIOM5B 2M8 CA CANADABNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN100 WEST 33RD STREET3RD FLOORNEW YORKNY NEW YORK10001 BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN100 WEST 33RD STREET3RD FLOORNEW YORKNY NEW YORK10001BNY MELLONPO BOX 392002500 ROSS STREETPITTSBURGHPA PENNSYLVANIA15262 US BNY MELLON/WEALTH MANAGEMENT1 FREEDOM VALLEY DRIVEOAKSPA PENNSYLVANIA19456 USBNYMELLON111 SANDERS CREEK PARKWAY 2ND FLOOR2ND FLOOREAST SYRACUSENY NEW YORK13057 US BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD.ONE WALL STREETNEW YORKNY NEW YORK10286BNYMELLON/RE CACEIS BANK LUXEMBOURG500 Grant St.BNY Mellon CenterPITTSBURGHPA PENNSYLVANIA15258 BNYMELLON/RE CACEIS BANK, NETHERLANDS111 SANDERS CREEK PARKWAYEAST SYRACUSENY NEW YORK13057BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED111 SANDERS CREEK PARKWAY 2ND FLOOR2ND FLOOREAST SYRACUSENY NEW YORK13057 US BNYMELLON/RE ETF - ISHARES DTC/NSCC111 SANDERS CREEK PARKWAYEAST SYRACUSENY NEW YORK13057BNYMELLON/RE WINTERFLOOD SECURITIES LTD500 Grant St.BNY Mellon CenterPITTSBURGHPA PENNSYLVANIA15258 BOFA4804 Deer Lake Drive EastFL9-803-04-04- 4th floorJACKSONVILLEFL FLORIDA32246 USBOFA4804 Deer Lake Drive EastFL9-803-04-04- 4th floorJACKSONVILLEFL FLORIDA32246 US BOFA SECURITIES INC4804 Deer Lake Drive EastFL9-803-04-04- 4th floorJACKSONVILLEFL FLORIDA32246 USBROWN BROTHERS HARRIMAN & CO.140 BROADWAYATTN: CORPORATE ACTIONS VAULTNEW YORKNY NEW YORK10005 US BROWN BROTHERS HARRIMAN & CO./ETF140 BROADWAYNEW YORKNY NEW YORK10005CALDWELL SECURITIES LTD./CDS**55 UNIVERSITY AVENUESUITE 340TORONTOON ONTARIOM5J 2H7 CANADA CANACCORD GENUITY CORP.609 GRANVILLE STVANCOUVERBC BRITISH COLUMBIAV7Y 1H2 CA CANADACANTOR, FITZGERALD & CO.135 E 57TH ST 5TH FLNEW YORKNY NEW YORK10041 US CDS CLEARING AND DEPOSITORY SERVICES INC.100 ADELAIDE STREET WESTTORONTOON ONTARIOM5H 1S3 CA CANADACETERA INVESTMENT SERVICES LLC400 FIRST STREET SOUTH, SUITE 300SUITE 300ST. CLOUDMN MINNESOTA56302-0283 US CHARLES SCHWAB & CO., INC.211 MAIN STREETSAN FRANCISCOCA CALIFORNIA94105 USCI INVESTMENT SERVICES INC.199 BAY STREETSUITE 2600TORONTOON ONTARIOM5L 1E2 CA CANADA CIBC WORLD MARKETS INC./CDS**161 BAY STREET 10 FLTORONTOON ONTARIOM5J 2S8 CA CANADACITIBANK, N.A./ETF3800 CITIGROUP CENTERB2/2TAMPAFL FLORIDA33610 CITIBANK, NATIONAL ASSOCIATION3800 CITIBANK CENTER TAMPABLDG.B FIRST FLOOR ZONE 8TAMPAFL FLORIDA33610-9122 USCITIGROUP GLOBAL MARKETS, INC.580 CROSSPOINT PARKWAYGETZVILLENY NEW YORK14068 US CLEAR STREET LLC4 World Trade Center, 45th Floor150 Greenwich StreetNEW YORKNY NEW YORK10007CLEARSTREET IO55 BROADWAY (SUITE 2102)CORPORATE ACTIONSNEW YORKNEW YORK10006 US COMMERCE BANK922 WALNUT STREETMAIL STOP TBTS-2KANSAS CITYMO MISSOURI64106 USCOR CLEARING LLC9300 UNDERWOOD AVESUITE 400OMAHANE NEBRASKA68114 US Credential Securities Inc.800-1111 WEST GEORGIA STREETVANCOUVERBC BRITISH COLUMBIAV6E 4T6 CA CANADACREST INTERNATIONAL NOMINEES LIMITED33 CANNON STREETLONDONEC4M 5SB GB UNITED KINGDO CURVATURE SECURITIES, LLC39 MAIN STREETCHATHAMNJ NEW JERSEY07928 USD.A. DAVIDSON & CO.8 3RD STREET NORTHGREAT FALLSMT MONTANA59401 US DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORESAVENIDA APOQUINDO # 4001FLOOR 12, C.P.7550162, SANTIAGOCL CHILEDESJARDINS SECURITIES INC.1253 McGill College10TH FLOORMONTREALQUEBECH3B 2Y5 CA CANADA DEUTSCHE BANK AG NY/US CUSTODY1251 Avenue Of The AmericasNEW YORKNY NEW YORK10020DEUTSCHE BANK SECURITIES INC.60 WALL STREET9TH FLOORNEW YORKNY NEW YORK10005 US DRIVEWEALTH, LLC15 EXCHANGE PLACE10TH FLOORJERSEY CITYNEW JERSEY07302E*TRADE CLEARING LLCHARBORSIDE FINANCIAL CENTER501 PLAZA 11JERSEY CITYNJ NEW JERSEY07311 US EDWARD D. JONES & CO., L.P.12555 MANCHESTER ROADST. LOUISMO MISSOURI63131-3729 USEDWARD D. JONES & CO., L.P.201 PROGRESS PARKWAYMARYLAND HEIGHTSMO MISSOURI63043 US FIDELITY CLEARING CANADA ULC/CDS**483 BAY ST.SOUTH TOWERTORONTOON ONTARIOM5G2N7 CA CANADAFIFTH THIRD BANK5001 KINGSLEY DRIVEMAIL DROP 1MOB28CINCINNATIOH OHIO45227 US FOLIO INVESTMENTS, INC.8180 GREENSBORO DRIVE8TH FLOORMCLEANVA VIRGINIA22102 USFUTU CLEARING INC.12750 Merit DriveSUITE 475DALLASTX TEXAS75251 GMP SECURITIES L.P.145 KING STREET WEST, SUITE 30011TH FLOORTORONTOON ONTARIOMJ5 1J8 CA CANADAGOLDMAN, SACHS & CO. LLC222 SOUTH MAIN STREETAttn: Mandatory Corporate ActionsSALT LAKE CITYUT UTAH84101 US HAYWOOD SECURITIES INC./CDS**200 BURRARD STWATERFRONT CENTRE SUITE 700VANCOUVERBC BRITISH COLUMBIAV6C 3L6 CANADAHILLTOP SECURITIES INC.1201 ELM ST.35TH FLOORDALLASTX TEXAS75270 US HRT FINANCIAL LLC150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER57TH FLOORNEW YORKNY NEW YORK10007 USHSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR STOCK LOAN452 FIFTH AVENUEATTN: HBUS CCS SETTSNEW YORKNY NEW YORK10018 US HSBC BANK USA, NATIONAL ASSOCIATION452 FIFTH AVENUEATTN: HBUS CCS SETTSNEW YORKNEW YORK10018 USINTERACTIVE BROKERS LLC2 PICKWICK PLAZA2ND FLOORGREENWICHCT CONNECTICUT06830 US J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF1111 POLARIS PARKWAYCOLUMBUSOH OHIO43240J.P. MORGAN CLEARING CORP.FOUR CHASE METROTECH CENTER3RD FLOORBROOKLYNNY NEW YORK11201 US JANNEY MONTGOMERY SCOTT LLC1717 ARCH STREET17TH FLOORPHILADELPHIAPA PENNSYLVANIA19103 USJEFFERIES LLC101 HUDSON STREET, 11th FloorNEW JERSEYNJ NEW JERSEY07302 US JPMORGAN CHASE BANK, NATIONAL ASSOCIATIONFOUR CHASE METROTECH CENTER3RD FLOORBROOKLYNNY NEW YORK11201 USJPMORGAN CHASE BANK/EUROCLEAR BANKFOUR CHASE METROTECH CENTER3RD FLOORBROOKLYNNY NEW YORK11245 US JPMORGAN CHASE BANK/IAFOUR CHASE METROTECH CENTER3RD FLOORBROOKLYNNY NEW YORK11201 USKEYBANK NATIONAL ASSOCIATION4900 TIEDEMAN RDBROOKLYNOH OHIO44144 US LAURENTIAN BANK SECURITIES INC.1981 MCGILL COLLEGE AVE.SUITE 100MONTREALQUEBECH3A 3K3 CA CANADALPL FINANCIAL LLC4707 EXECUTIVE DRIVESAN DIEGOCA CALIFORNIA92121 US MANUFACTURERS AND TRADERS TRUST COMPANYONE M&T PLAZATRUST OPS 8TH FLOORBUFFALONY NEW YORK14203 USMANULIFE SECURITIES INCORPORATED1235 NORTH SERVICE ROAD WESTOAKVILLEON ONTARIOL6M 2W2 CA CANADA MARSCO INVESTMENT CORPORATION101 EISENHOWER PARKWAYROSELANDNJ NEW JERSEY07068 USMERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED4804 Deer Lake Drive EastFL9-803-04-04- 4th floorJACKSONVILLEFL FLORIDA32246 US MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT810 SEVENTH AVE37TH FLOORNEW YORKNY NEW YORK10019MIRAE ASSET SECURITIES (USA), INC.810 SEVENTH AVE37TH FLOORNEW YORKNY NEW YORK10019 MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH280 PARK AVE39TH FL-WEST BLDGNEW YORKNY NEW YORK10017Morgan Stanley1300 THAMES STREETTHAMES STREET WHARFBALTIMOREMD MARYLAND21231 US MORGAN STANLEY & CO. LLC1300 THAMES ST.BALTIMOREMD MARYLANDMORGAN STANLEY SMITH BARNEY LLC1 NEW YORK PLAZA39TH FLOORNEW YORKNY NEW YORK10004 US MURIEL SIEBERT & CO., INC.77 SUMMER STREET3RD FLOORBOSTONMA MASSACHUSETTS02210 USNATIONAL FINANCIAL SERVICES LLC499 WASHINGTON BOULEVARD5TH FLOORJERSEY CITYNJ NEW JERSEY07310 US NBCN INC.1010 rue De La GauchetièreMezzanine 100MONTREALQUEBECH3B 5J2 CA CANADANOMURA INTERNATIONAL TRUST COMPANY309 WEST 49TH STREET10TH FLOORNEW YORKNY NEW YORK10019 US ODLUM BROWN LIMITED250 HOWE STREETSUITE 1100VANCOUVERBC BRITISH COLUMBIAV6C 3R8 CA CANADAOPPENHEIMER & CO. INC.85 BROAD STREETNEW YORKNY NEW YORK10004 US PERSHING LLC1 PERSHING PLAZAJERSEY CITYNJ NEW JERSEY07399 USPHILLIP CAPITAL INC.141 W. JACKSON BLVD. SUITE 3050CHICAGOIL ILLINOIS60604 US PI FINANCIAL CORP.666 BURRARD STSUITE 1900VANCOUVERBC BRITISH COLUMBIAV6C 3N1 CA CANADAPNC BANK, NATIONAL ASSOCIATION4100 W 150TH STREETASSET MOVEMENT TEAM 3RD FL, LOCATOR B7-YB17-03-03CLEVELANDOH OHIO44135 US PRINCIPAL BANK711 HIGH STREETDES MOINESIA IOWA50392QUESTRADE INC./CDS**5650 YONGE ST.,Suite 1700TORONTOON ONTARIOM2M 4G3 CA CANADA Raymond James & Associates, Inc.880 CARILLON PKWYST. PETERSBURGFL FLORIDA33733-2749 USRAYMOND JAMES LTD.925 WEST GEORGIA STREETSUITE 2200VANCOUVERBC BRITISH COLUMBIAV6C 3L2 CA CANADA RBC CAPITAL MARKETS, LLC60 SOUTH 6TH ST.MINNEAPOLISMN MINNESOTA55402 USRBC DOMINION SECURITIES INC21 COMMERCE COURT SOUTH2ND FLOORTORONTOON ONTARIOM5L 1A7 CANADA RELIANCE TRUST COMPANY1100 ABERNATHY RD.500 NORTHPARK SUITE 400ATLANTAGA GEORGIA30113 USRELIANCE TRUST COMPANY4900 W. BROWN DEER RDMILWAUKEEWI WISCONSIN53223 US ROBERT W. BAIRD & CO. INCORPORATED777 E WISCONSIN AVE9TH FLOORMILWAUKEEWI WISCONSIN53202 USROBINHOOD SECURITIES, LLC500 COLONIAL CENTER PARKWAYSUITE 100LAKE MARYFL FLORIDA32746 US SAFRA SECURITIES LLC546 5TH AVENUENEW YORKNY NEW YORK10036 USSCOTIA CAPITAL (USA) INC.150 KING STREET W5TH FLOORTORONTOON ONTARIOM5H 1J9 CA CANADA SEI PRIVATE TRUST COMPANY1 FREEDOM VALLEY DRIVEOAKSPA PENNSYLVANIA19456 USSEI PRIVATE TRUST COMPANY1 FREEDOM VALLEY DRIVEOAKSPA PENNSYLVANIA19456 US SG AMERICAS SECURITIES, LLC480 WASHINGTON BLVD.20TH FLOORJERSEY CITYNJ NEW JERSEY07310 USSSB - BLACKROCK INSTITUTIONAL TRUST50 California StreetSan FranciscoCA CALIFORNIA94163 SSB - TRUST CUSTODY30 ADELAIDE ST EASTSUITE 800TORONTOON ONTARIOM5C 3G6 CA CANADASSB&T CO/CLIENT CUSTODY SERVICES1776 HERITAGE DRIVENORTH QUINCYMA MASSACHUSETTS02171 STATE STREET BANK & TRUST CO16 WALL STREET5TH FLOORNEW YORKNY NEW YORK10005 USSTATE STREET BANK & TRUST COMPANY / ISHARES EUROPE1776 HERITAGE DRIVENORTH QUINCYMA MASSACHUSETTS02171 STATE STREET BANK & TRUST/STATE STREET TOTALETF1776 Heritage DriveNORTH QUINCYMA MASSACHUSETTS02717STATE STREET BANK AND TRUST COMPANY30 ADELAIDE ST EASTSUITE 800TORONTOON ONTARIOM5C 3G6 CA CANADA STIFEL, NICOLAUS & COMPANY, INCORPORATED501 N BROADWAYST. LOUISMO MISSOURI63102 USSTONEX FINANCIAL INC.2 PERIMETER PARK SOUTHSUITE 100 WBIRMINGHAMAL ALABAMA35243 US TD AMERITRADE CLEARING, INC.200 S 108TH AVEOMAHANE NEBRASKA68154 USTD WATERHOUSE CANADA INCATTN: MANDATORY CORPORATE ACTIONS77 BLOOR STREET WEST3RD FLOORTORONTOON ONTARIOM5S 1M2 CA CANADA TEXAS TREASURY SAFEKEEPING TRUST COMPANY208 E 10TH STAUSTINTX TEXAS78701 USTHE BANK OF NEW YORK MELLON500 GRANT STREET27TH FLOORPITTSBURGHPA PENNSYLVANIA15258 US THE HUNTINGTON NATIONAL BANK7 EASTON OVAL EA4E62COLUMBUSOH OHIO43209 USTHE NORTHERN TRUST COMPANY333 South Wabash Ave, 32nd FloorAttn: Trade Securities ProcessingCHICAGOIL ILLINOIS60603 US TRADESTATION SECURITIES, INC.120 RIVERSIDE PLAZASUITE 1650CHICAGOIL ILLINOIS60606 USU.S. BANCORP INVESTMENTS, INC.60 LIVINGSTON AVEEP-MN-WN1BST. PAULMN MINNESOTA55107-1419 US U.S. BANK N.A./ETF1555 N RIVER CENTER DRIVEMILWAUKEEWI WISCONSIN53212U.S. BANK NATIONAL ASSOCIATION1555 NORTH RIVERCENTER DRIVE, SUITE 302SUITE 302MILWAUKEEWI WISCONSIN53212 US UBS AG480 WASHINGTON BLVD.12TH FLOORJERSEY CITYNJ NEW JERSEY07310 USUBS FINANCIAL SERVICES INC.1000 HARBOR BOULEVARDWEEHAWKENNJ NEW JERSEY07086 US UBS SECURITIES LLC677 WASHINGTON BLVDSTAMFORDCT CONNECTICUT06901 USUMB BANK, NATIONAL ASSOCIATION928 GRAND BLVDKANSAS CITYMO MISSOURI64106 US VANGUARD MARKETING CORPORATION100 VANGUARD BLVDMALVERNPA PENNSYLVANIA19355 USVELOCITY CLEARING, LLC1301 Route 36Suite 109 (Attn: Chris Felicetti)HAZLETNEW JERSEY7730 US VELOX CLEARING LLC2400 E. KATELLA AVENUESUITE 725AANAHEIMCA CALIFORNIA92806 USVIRTU AMERICAS LLCONE LIBERTY PLAZA, 165 BROADWAY5TH FLOORNEW YORKNY NEW YORK10006 US VISION FINANCIAL MARKETS LLC4 HIGH RIDGE PARKSUITE 100STAMFORDCT CONNECTICUT06905 USWEDBUSH SECURITIES INC1000 WILSHIRE BLVD8TH FLOORLOS ANGELESCA CALIFORNIA90017 US WEDBUSH SECURITIES INC.1000 WILSHIRE BLVD.LOS ANGELESCA CALIFORNIA90017 USWELLS FARGO BANK, N.A./SIG733 MARQUETTE AVE 4TH FLOORMAC N9306-04DMINNEAPOLISMN MINNESOTA55402 US WELLS FARGO CLEARING SERVICES LLC1 NORTH JEFFERSONMAIL CODE: H0006-094ST. LOUISMO MISSOURI63103 USWELLS FARGO SECURITIES, LLC1525 WEST W T HARRIS BLVDCHARLOTTENC NORTH CAROLINA28262 US WILSON-DAVIS & CO., INC.236 SOUTH MAIN STREETSALT LAKE CITYUT UTAH84101 US About Scilex Holding Company
Scilex Holding Company, a majority-owned by Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex has applied for breakthrough therapy designation and expects to seek priority review for SEMDEXA™ for the treatment of sciatica. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain. Scilex launched its first commercial product in October 2018, in-licensed a commercial product in June 2022, and is developing its late-stage pipeline, which includes a pivotal Phase 3 candidate and one Phase 2 and one Phase 1 candidate. Its commercial product, ZTlido® (lidocaine topical system) 1.8%, or ZTlido®, is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. Scilex in-licensed the exclusive right to commercialize Gloperba® (colchicine USP) oral solution, an FDA-approved prophylactic treatment for painful gout flares in adults, in the U.S. Scilex is planning to commercialize Gloperba® in 2023 and is well-positioned to market and distribute the product. Scilex’s three product candidates are SP-102 (injectable dexamethasone sodium phosphate viscous gel product containing 10 mg dexamethasone), or SEMDEXA™, a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, with FDA Fast Track status; SP-103 (lidocaine topical system) 5.4%, a Phase 2, triple-strength formulation of ZTlido®, for the treatment of low back pain, with FDA Fast Track status; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia that has completed multiple Phase 1 trial programs and expected to initiate Phase 2 trials this year. For further information regarding the SP-102 Phase 3 efficacy trial, see NCT identifier NCT03372161 – Corticosteroid Lumbar Epidural Analgesia for Radiculopathy – Full Text View – ClinicalTrials.gov. Scilex Holding Company is headquartered in Palo Alto, California, with operations in both Palo Alto and San Diego, California. For further information please visit www.scilexholding.com. About Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors (“TKIs”), fully human antibodies (“G-MAB™ library”), immuno-cellular therapies (“DAR-T™”), antibody-drug conjugates (“ADCs”), and oncolytic virus (“Seprehvec™”). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™. Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin (“RTX”), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018. For more information visit www.sorrentotherapeutics.com. Contacts: For Scilex Holding Company Jaisim ShahChief Executive OfficerScilex Holding Company960 San Antonio RoadPalo Alto, CA 94303Office: (650) 516-4310 Email: jshah@scilexpharma.com Website: www.sorrentotherapeutics.com and www.scilexholding.com Investors and Media Contact:Elizabeth CzerepakEmail: mediarelations@sorrentotherapeutics.comWebsite: www.sorrentotherapeutics.com Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc. G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of Sorrento Therapeutics, Inc. SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is an exclusive, transferable license to use the trademark by Scilex Holding Company. All other trademarks are the property of their respective owners.
© 2023 Sorrento Therapeutics, Inc. All Rights Reserved.